Respiratory Therapy and Breathwork

Download this page as PDF · Summary

1. What Respiratory Therapy and Breathwork Are

Both approaches aim to modulate the autonomic nervous system, for example, via baroreflex sensitivity or heart rate variability (HRV). Implementation varies from single biofeedback sessions to multi-week rehabilitation programmes.

Diversity of measurement parameters is critical: breathing techniques are assessed via subjective scales (e.g., dyspnoea, stress), physiological markers (HRV, blood pressure, oxygen saturation), or functional tests (6-minute walk test, cognitive performance). Many studies use biofeedback as a control condition, which complicates the isolation of specific effects. Additionally, a standardised terminology is lacking—terms like pursed-lip breathing, slow breathing, or yogic breathing overlap despite describing distinct breathing patterns (frequency, depth, nasal/mouth breathing). Intervention duration ranges from single sessions to multi-month programmes, limiting direct comparisons.

2. What the Studies Show in Detail

The foundational human studies and key reviews are organised by application, including population, duration, preparation, outcome measures, and results as reported in the original publications. Numbers are included only where explicitly stated in the source.

Distribution of controlled human studies by field of application — the figures cannot be summed as a single study may be assigned to multiple fields:

Musculoskeletal System and Respiratory Function in Chronic Lung Diseases

A randomised controlled trial involving 60 patients (mean age 65 ± 7 years, FEV₁ 35 ± 14%) with moderate to severe COPD assessed an outpatient pulmonary rehabilitation programme over 3 months. The intervention group received breathing training, chest physiotherapy, daily supervised exercise (3 months) and weekly breathing exercises (6 months). The control group received standard care. Outcomes measured included dyspnoea (Chronic Respiratory Questionnaire, CRQ), 6-minute walk test (6MWT) distance, and hospitalisation rate. The intervention group demonstrated significant improvements in dyspnoea (p < 0.0001), walking distance (p < 0.0001), and CRQ subscales for daily dyspnoea, fatigue, and emotional function (p < 0.01). Effects persisted with slightly reduced magnitude over 24 months. Exacerbations decreased significantly (p < 0.0001), though hospitalisations did not. Limitations included the lack of participant blinding and the small sample size, which precluded subgroup analyses 1.

A multicentre, randomised controlled crossover trial examined a 3-month rehabilitation programme (breathing training, mucus clearance, relaxation, and exercise training) in asthma and COPD patients (sample size not explicitly stated). After 3 months, significant improvements were observed in endurance time (421 s), heart rate (6 beats/min), 6MWT distance (39 m), and total CRQ score (17 points) compared with the control group (medication only). Effects were sustained at 6 months. Asthma and COPD patients benefited similarly, except for walking distance (greater effect in asthma). Limitations included the lack of blinding and unclear group sample sizes 2.

A pilot study involving 29 stable COPD patients (mean age 69.9 ± 9.5 years, FEV₁ 47.7 ± 15.6%; 21 women) compared 12 weeks of yoga (twice weekly, including asanas and visama vritti pranayama) with standard care. Primary endpoints were dyspnoea intensity (DI) and dyspnoea distress (DD) during ergometry and the 6-minute walk test (6MWT). Secondary endpoints included physical performance, psychological well-being, and quality of life. Yoga was safe and feasible, reducing DD after the 6MWT (effect size 0.34), but not DI. Limitations included the small sample size and the absence of an active control group 4.

A Cochrane Review (2012) analysed randomised studies on breathing exercises in COPD. Primary endpoints were dyspnoea, exercise capacity, and quality of life. The meta-analysis showed inconsistent effects: some studies reported improvements in dyspnoea and exercise capacity, while others did not. The quality of evidence was low, as many studies had small sample sizes, short intervention durations (typically < 3 months), and heterogeneous breathing techniques. Systematic comparisons between techniques (e.g., pursed-lip breathing vs. diaphragmatic breathing) were lacking 7.

Hypothesis The studies suggest that breathing therapy in COPD and asthma may primarily act through optimisation of respiratory mechanics (e.g., reduction of dynamic hyperinflation) and improved exercise tolerance. Long-term efficacy could be mediated by a reduction in exacerbations and enhanced body awareness. However, which specific techniques work at which disease severity, and how their efficacy differs, remains to be clarified.

Inflammatory Processes and Autonomic Regulation

A randomised controlled trial involving 24 healthy participants examined the effects of a 10-day training programme (meditation, cyclic hyperventilation with breath retention, cold exposure) on cytokine levels following intravenous administration of E. coli endotoxin (2 ng/kg). The intervention group showed a faster and more pronounced increase in the anti-inflammatory cytokine IL-10, correlating with elevated adrenaline levels. Pro-inflammatory cytokines (TNF-α, IL-6, IL-8) were significantly reduced. The technique induced intermittent respiratory alkalosis and hypoxia. Limitations included the small sample size and lack of blinding.

In the study, the primary endpoint was asthma-specific quality of life (AQLQ), a patient-reported outcome measured via questionnaire. Effects on this measure were no longer significant after 12 months, indicating no sustained improvement in asthma-related quality of life. Limitations included the lack of blinding and a high dropout rate (30%) 6.

Hypothesis The data suggest that a combined programme of meditation, breathing exercises, and cold exposure may exert anti-inflammatory effects through modulation of the autonomic nervous system (e.g., increased parasympathetic activity). Short-term improvements in quality of life in asthma could be explained by reduced dyspnoea and enhanced self-efficacy. However, studies directly investigating these mechanisms in patients with chronic inflammatory conditions have yet to be conducted.

Cognition, Psyche, and Stress Regulation

A randomised controlled trial involving 126 participants compared three stress-reduction interventions—physical activity (PA), mindfulness meditation (MM), and heart rate variability biofeedback (HRV-BF), which includes breathwork components—on stress, anxiety, depressive symptoms, and psychological well-being. All interventions, including the breathwork-based HRV-BF, led to significant improvements (p < 0.05), with no differences between groups. The study does not isolate the effects of breathwork alone.

A randomised controlled trial involving 46 musicians examined the effect of a 30-minute HRV-BF session (slow breathing with/without biofeedback) on performance anxiety (STAI-S) and HRV. The intervention groups showed significant increases in high-frequency HRV (η² = 0.122) and reductions in the LF/HF ratio (η² = 0.116) during the anticipation phase. Performance anxiety did not decrease significantly. Limitations included the short intervention duration and the lack of follow-up measurements.

A meta-analysis (2023) involving 785 participants from 12 randomised studies demonstrated that breathing exercises (e.g., slow breathing, coherent breathing) significantly reduced subjective stress (effect size g = -0.35; p = 0.0009). Similar effects were observed for anxiety (g = -0.32) and depressive symptoms (g = -0.40). Heterogeneity was moderate (I² = 42%). Limitations included variability in breathing techniques and the lack of differentiation by duration or intensity 5.

The intervention group showed significant improvements in the MBHI subscales for introverted, assertive, and sensitive personality styles (p ≤ 0.05), as well as in the SCL-90-R scales for depression, hostility, and global symptom severity (p ≤ 0.01), suggesting potential psychometric effects. Clinical validation of these findings is still pending.

Hypothesis The data indicate that breathing techniques may reduce stress through synchronisation of respiration and autonomic regulation (e.g., increased HRV). Effects on cognition and psyche could be mediated by improved interoceptive awareness and reduced sympathetic overactivation. However, studies directly investigating these mechanisms using neuroimaging (e.g., fMRI) or neurophysiological markers (e.g., EEG) are still pending.

Fatigue and Stress

Primary endpoints were walking distance (6MWT), quality of life, and dyspnoea (Mahler Index). After 6 weeks, no significant differences were observed. After 6 months, the Mahler Transition Index showed an improvement in the intervention group (p < 0.05), providing an initial indication that requires further investigation.

Primary endpoints were health-related quality of life (HRQoL) and mental health (PHQ-9, GAD-7).

A systematic review (2018) analysed psychophysiological correlates of slow breathing (< 10 breaths/min). Slow breathing increased HRV and respiratory sinus arrhythmia, reduced sympathetic activity, and modulated EEG activity (increase in alpha waves, decrease in theta waves). Limitations included study heterogeneity and the lack of long-term data 12.

Hypothesis The data suggest that breathing techniques may alleviate fatigue and stress through improved autonomic regulation (e.g., increased HRV) and reduced hyperventilation. Effects in Long-COVID could be mediated by enhanced body awareness and reduced dyspnoea. However, whether these mechanisms operate in specific fatigue syndromes (e.g., ME/CFS) remains an open question.

Heart and Circulation

A randomised controlled trial involving 60 patients with essential hypertension (stage 1) compared 3 months of slow (6 breaths/min) and fast (12 breaths/min) breathing exercises with a control group. Primary endpoints were blood pressure (BP) and autonomic function tests (e.g., Valsalva manoeuvre, E/I ratio). Slow breathing significantly reduced BP (p < 0.05) and improved autonomic regulation. Fast breathing showed smaller effects. Limitations included the lack of blinding and the short intervention duration 9.

A study involving 23 healthy adults examined the effects of rosary prayer (6 breaths/min) and yoga mantras on cardiovascular rhythms. Both techniques led to synchronous increases in cardiovascular oscillations and a significant enhancement of baroreflex sensitivity (from 9.5 ± 4.6 to 11.5 ± 4.9 ms/mmHg; p < 0.05), a surrogate marker for autonomic regulation. Limitations included the lack of a control group and the small sample size 13.

Hypothesis The data suggest that slow breathing techniques may improve cardiovascular regulation through synchronisation of respiration and the baroreflex. Effects on blood pressure could be mediated by reduced sympathetic activity and improved vascular regulation. However, whether these mechanisms operate in patients with cardiovascular diseases (e.g., heart failure) remains an open question.

Oncology

A randomised controlled pilot study involving 16 cancer patients undergoing chemotherapy examined pranayama (4 breathing techniques, weekly sessions + home practice) for potential effects on fatigue, sleep disturbances, anxiety, and quality of life. The study provides initial insights; whether these effects translate into clinical outcomes remains to be examined.

Hypothesis The data suggest that breathing techniques in cancer patients may act through a reduction in stress responses and improved body awareness. However, studies with larger sample sizes and longer follow-up periods are needed to assess the clinical relevance of these effects.

Overall Picture

The available studies consistently demonstrate that respiratory therapy and breathwork have positive effects on both physical and psychological parameters across a range of indications. Improvements in respiratory function and exercise capacity in COPD, reductions in stress and anxiety, and modulation of autonomic regulation (e.g., increased heart rate variability, HRV) are particularly well documented in preclinical models. Early clinical settings suggest similar effects, but these findings require further investigation to confirm their translation to sustained clinical benefits in humans. These effects appear to be mediated through several mechanisms: optimisation of respiratory mechanics (e.g., reduction of dynamic hyperinflation), synchronisation of breathing and cardiovascular regulation (e.g., baroreflex sensitivity), and enhanced interoceptive awareness and self-efficacy.

However, evidence for some applications (e.g., oncology, immune modulation) remains limited, and study quality is often constrained by small sample sizes, lack of blinding, and short intervention durations. Furthermore, systematic comparisons between different breathing techniques (e.g., diaphragmatic breathing vs. pursed-lip breathing) and their differential efficacy in specific patient groups are lacking. Long-term data on the sustainability of effects are also scarce.

3. How Robust the Research Is

The efficacy studies cover fatigue, cognition, and the musculoskeletal system, followed by safety, cardiovascular health, and oncology. The most frequently cited studies originate from pulmonary rehabilitation (COPD) and stress research, where biofeedback and slow breathing rates are considered established methods. Review articles on various interventions, including breathwork among others, dominate mechanistic research, such as studies on vagal stimulation or baroreflex modulation. Observational studies prevail in the investigation of psychophysiological correlates (e.g., HRV and emotions), while controlled efficacy studies for chronic conditions (e.g., asthma, hypertension) are less common.

The methodological robustness varies significantly: pulmonary rehabilitation and stress reduction benefit from large, randomised studies with clinical endpoints (e.g., quality of life, hospitalisation rates). However, for cognitive effects or chronic pain, long-term follow-ups are lacking. Biofeedback studies often demonstrate short-term physiological changes without correlating these with clinical improvements. Breathwork is frequently studied in non-clinical populations (e.g., musicians, athletes), which limits generalizability to patients. Critically, the heterogeneity of interventions—even among similar breathing techniques—differs in frequency, duration, and instruction, complicating meta-analyses.

4. Common Claims—and What the Data Actually Show

5. The Most Robust Studies

Ranked by evidential strength, not by prominence. The full evaluation includes many more studies; only the most reliable are listed here.

Controlled Human Studies

• 1 Long-term effects of outpatient rehabilitation of COPD: A randomised trial (2000)
• Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans (2014)
• 2 The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomised controlled trial (1997)
• Physical activity, mindfulness meditation, or heart rate variability biofeedback for stress reduction: a randomised controlled trial (2015)
• Mechanisms of nasal high flow on ventilation during wakefulness and sleep (2013)
• 3 Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial (2003)
• Matter over mind: a randomised-controlled trial of single-session biofeedback training on performance anxiety and heart rate variability in musicians (2012)
• Yoga as a Therapeutic Intervention: A Bibliometric Analysis of Published Research Studies from 1967 to 2013 (2015)
• 4 Yoga therapy decreases dyspnoea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study (2009)
• 5 Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials (2023)
• Yoga breathing for cancer chemotherapy-associated symptoms and quality of life: results of a pilot randomised controlled trial (2012)
• 6 Physiotherapy breathing retraining for asthma: a randomised controlled trial (2018)
• 7 Breathing exercises for chronic obstructive pulmonary disease (2012)
• 8 Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD (2006)
• Treatment of dyspnoea in COPD. A controlled clinical trial of dyspnoea management strategies (1995)
• 9 Effect of slow- and fast-breathing exercises on autonomic functions in patients with essential hypertension (2009)
• 10 Effects of Diaphragmatic Breathing on Health: A Narrative Review (2020)
• 11 An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial (2022)
• Mechanistic Pathways of Mindfulness Meditation in Combat Veterans With Posttraumatic Stress Disorder (2016)
• Short-Term Effects of a Respiratory Telerehabilitation Programme in Confined COVID-19 Patients in the Acute Phase: A Pilot Study (2021)
• Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing (2004)
• The Role of Heart Rate Variability in Mindfulness-Based Pain Relief (2020)
• Effects of Preoperative Breathing Exercise on Postoperative Outcomes for Patients With Lung Cancer Undergoing Curative Intent Lung Resection: A Meta-Analysis (2021)
• Aerobic and breathing exercises improve dyspnoea, exercise capacity and quality of life in idiopathic pulmonary fibrosis patients: systematic review and meta-analysis (2020)

6. Summary

The available studies consistently demonstrate positive effects of breathing therapy and breathwork on physical and psychological parameters, particularly in COPD (respiratory function, exercise capacity), stress and anxiety reduction, and modulation of autonomic regulation (e.g., increased HRV). Mechanisms include optimisation of breathing mechanics, synchronisation of respiration and cardiovascular regulation, and improved interoceptive awareness. Pulmonary rehabilitation and stress research are particularly well-studied, with large, randomised trials featuring clinical endpoints. However, evidence remains limited for some applications, such as oncology or immunomodulation, and methodological quality is often constrained by small sample sizes or lack of long-term data.

In chronic conditions such as asthma or hypertension, long-term effects could be explained by reductions in dyspnoea, improved self-efficacy, and optimised vascular regulation. Short-term cognitive and psychological effects may stem from synchronisation of breathing and autonomic regulation, as well as reduced sympathetic overactivation. Furthermore, efficacy may vary across disease severities, necessitating systematic comparisons between breathing techniques.

Future studies should clarify which specific breathing techniques (e.g., diaphragmatic breathing vs. pursed-lip breathing) are most effective for which indications and patient groups. Long-term follow-up is needed to assess the clinical relevance and sustainability of effects in chronic diseases. Additionally, mechanisms such as autonomic regulation or anti-inflammatory effects should be directly investigated using imaging techniques (fMRI) or neurophysiological markers (EEG). Standardised terminology and intervention protocols would facilitate meta-analyses and comparisons between studies. Finally, data on differential efficacy in subgroups, such as by disease severity or comorbidities, are lacking.

7. Unresolved Questions

• Standardisation: Is there an optimal respiratory rate or duration for specific indications, or are effects highly individual?
• Long-term effects: Do breathing techniques have a sustained impact on chronic conditions (e.g., hypertension, diabetes), or are the effects short-term?
• Combination therapies: Can breathing techniques be used synergistically with medication or physiotherapy, or are there interactions?